Equipment

The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.

Gregor Kawaletz, head of Oral Solid Dose Business Unit at Recipharm, discusses the immediate future of oral biologics

Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.

Decreasing vein to vein time saves lives.

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.

The trends shaping the growth of the biologics outsourcing industry demand attention.

To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.

In addition, personnel, equipment, and facilities from the acquired companies will expand Reaction Biology’s presence in Germany while enabling its global customers to leverage Bioassay’s expansive portfolio of regulated clinical and commercial services.

Overall industry growth conceals growing numbers of smaller, faster-paced, adaptable corporate structures.

Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.

Data analytics, modular equipment, digital tools, and risk-based validation improve speed, flexibility, and quality.

Steriline will be exhibiting its vial filling and capping machine (VFCM100) under double-wall isolator for aseptic filling at CPHI 2022 in Frankfurt, Germany, on Nov. 1–3, 2022.

Documentation is crucial to equipment qualification, says Siegfried Schmitt, vice president, Technical at Parexel.

Recipharm’s new high speed filling line, designed for pre-filled syringes and cartridges, is expected to be operational by May 2023.

Product safety and security are paramount when it comes to container closures.

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.

Freudenberg Medical’s Heflix TPE tubing is a high purity TPE intended for bioprocessing applications.

BFS technology can help maintain sterility during the biologics manufacturing process.

Choosing low-adsorption glass vials helps ensure detection accuracy.

Automation enables intensification of downstream processes.

Watson-Marlow and Franz Ziel GmbH have launched a new integrated solution to fast-track cell, gene, and biological therapies.

Grand River Aseptic Manufacturing has completed phase II of its facility expansion with the installation of two new sterile filling lines.

Point-of-use manufacturing may lead to a big change in the accessibility of medicines globally.

Getinge’s new DPTE-EXO with Sleeveless DPTE-BetaBag is an alpha port with an external opening and an integrated funnel for automated aseptic transfer.

MilliporeSigma’s new BioContinuum Seed Train Platform offering enables a fully closed bioprocessing environment for both fed-batch and perfusion N-production.

Merck has entered into a collaboration with Agilent Technologies with the aim of filling the industry gap in PAT for downstream processing.

This article explores the concerns with cleaning pharmaceutical products utilizing LNP delivery vehicles and provides a general cleaning recommendation based on laboratory and field testing.

Flexible and efficient methods are needed for biopharmaceutical manufacturing.

By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.